Northpond Ventures

United States · VC · DeepTech Specialist

About

Northpond Ventures Northpond Ventures is a life sciences and technology-focused VC with 74 portfolio companies, 5 IPOs, and 12 acquisitions including 908 Devices, Syapse, and Sherlock Biosciences. The fund has maintained consistent deployment with 6 investments in 2024 and 4 in early 2025, showing sustained activity in a market where many life sciences investors pulled back. The synthetic biology angle is particularly strong: Northpond led a $21M financing alongside Novalis LifeSciences in synth

Industries

Stage focus

Geography

Notable investments

908 Devices
Syapse
Sherlock

Request removal →

Raising from Northpond Ventures?

I've worked with founders across the industrial stack. If Northpond Ventures is on your list, I can help you map the introduction path, sharpen the narrative, and run a tight process.

Talk to Dan